Related Experiment Video
Updated: Sep 12, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients
Jennifer Erley1, Julia Breckow2, Kevin Roedl3
1Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. j.erley@uke.de.
Objectives:
To analyze changes in the liver dual-energy CT fat fraction (liver DECT FF) at the intensive care unit (ICU), and its prognostic value.
Materials And Methods:
Intubated ICU patients were retrospectively included, who received two clinical DECT (CT1 and CT2) within a minimum interval of 10 days between 11/2019 and 12/2022. The liver DECT FF was determined by combining two regions of interest (ROI) in the right and one ROI in the left liver lobe (minimum area 3.6 cm2). The skeletal muscle index, muscle radiodensity attenuation, subcutaneous/visceral adipose tissue area, and waist circumference were assessed. Pre-existing diseases, reasons for ICU admission, ICU scoring systems, and in-hospital mortality were noted. t-tests, Wilcoxon tests, linear or Cox regression, Pearson correlation, and intraclass correlation coefficients (ICC) were employed.
Results:
Of 76 total patients, 43.4% were female (age 61 ± 12 years) and 97.4% received parenteral nutrition. In-hospital mortality was 60.8%. The liver DECT FF at CT1 was the only parameter associated with in-hospital mortality (hazard ratio: 1.15 [95% confidence interval: 1.07-1.24], p < 0.001), and a shorter ICU stay (-3.66 [-6.29 to -1.02] days, p < 0.007). DECT FF was not associated with ICU scoring systems. It did not relevantly change within a median of 8 days (3.3 ± 5.5% at CT1; 2.7 ± 4.3% at CT2, p = 0.315). Subset inter-observer reproducibility was good (ICC: 0.87 [0.66-0.95]).
Conclusion:
The liver DECT FF may serve as an independent prognostic imaging biomarker of mortality in critically ill patients, with a superior value to single-energy body composition parameters.
Key Points:
Question Although the risk of liver steatosis is increased in critically ill patients, it is unknown if liver fat content, when quantified using DECT, is of prognostic value. Findings The liver DECT FF is associated with in-hospital mortality in critically ill patients. Clinical relevance The liver DECT FF may be superior for survival prognosis than single-energy CT body composition parameters of muscle and fat tissue at the ICU.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Imaging Studies for Cardiovascular System V: CT

